AUAUniversity Podcast Series: Episode No. 100
AUA2021 Kick Off Weekend: Diagnosis & Management of Localized & Advanced Kidney Cancer
Support provided by independent educational grants from AstraZeneca, Bristol Myers Squibb and Merck.
At the conclusion of the activity, participants will be able to:
- Differentiate among the subtypes of kidney cancer, with emphasis on clinical management decisions and outline ways in which knowledge of kidney cancer subtypes can alter surgical approach.
- Apply advanced strategies for partial nephrectomy for patients with endophytic, hilar and multiple tumors including role of warm ischemia, intraoperative ultrasound, techniques for hemostatic control, the role of off-clamp and selective hilar clamping, the use of the retroperitoneal approach, and methods for renorrhaphy.
- Employ techniques for management of large and/or locally advanced tumors including management of renal vein or inferior vena cava invasion and the use of lymphadenectomy.
- Identify the role of cytoreductive nephrectomy and/or resection of metastatic foci in patients with advanced disease.
- Describe new and emerging targeted therapy and immuno-oncology options for patients with locally-advanced and advanced kidney cancer and the role of adjuvant therapy.
Course Director: W. Marston Linehan, MD
Faculty: Mark Ball, MD
David McDermott, MD
Ramaprasad Srinivasan, MD, PhD